Skip to content

Effects of Functional Exercise Program With Strength Load and Resistance in Children and Adolescents With Cerebral Palsy

Effects of Functional Exercise Program With Strength Load and Resistance in Gross Motor Function, Quality of Life and Participation in Children and Adolescents With Cerebral Palsy Levels III-IV GMFCS

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06820398
Acronym
FESCA_CP
Enrollment
40
Registered
2025-02-11
Start date
2025-01-31
Completion date
2028-12-31
Last updated
2025-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy

Keywords

Functional Exercise, Strength, Resistance, Children, Adolescents

Brief summary

This research project aims to evaluate the benefits of a functional exercise program with strength and resistance load in adolescents with cerebral palsy (CP), specifically classifiedat levels III and IV of the Gross Motor Function Classification System (GMFCS) scale. Participants will be included into control or intervention group in this randomized controlled trial. Changes in functional percentile, quality of life, and participation in daily environments will be analyzed based on scores obtained with validated assesment scales. The study will be conducted at the Children's Neurorehabilitation Unit of Hospitalarias Foundation in Valencia, with an 18-week intervention plus a 6-month follow-up. This project seeks to provide evidence on rehabilitation strategies that promote autonomy and social inclusion for this population.

Detailed description

This research project is a randomized controlled trial designed to analyze the effects of a functional exercise program with strength and resistance load in adolescents with CP specifically classified at levels III and IV of the GMFCS scale. The study will include around 40 participants aged 10 to 18 years, randomly assigned to either an intervention group or a control group. The intervention group will perform functional exercises with progressive strength and resistance load, adjusted based on heart rate. The control group will perform the same functional exercises but without any load. The protocol includes 36 sessions over 18 weeks, with evaluations at three key time points: before the intervention, at the end of the protocol, and six months post-intervention. The primary outcomes include functional percentile within the GMFCS, quality of life asperceived by patients and caregivers, and participation in daily environments. The study will adhere to CONSORT guidelines and the Declaration of Helsinki and has been reviewed by an ethics committee.

Interventions

OTHERFunctional exercise with progressive strength and resistance load

This group will perform functional exercises with progressive strength and resistance load, adjusted based on heart rate.

OTHERFunctional exercises without any load

This group will perform functional exercises, without strength or resistance load

Sponsors

University of Valencia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
10 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Adolescents aged 10 to 18 years. * Diagnosis of spastic cerebral palsy (CP). * Classification at levels III or IV of the GMFCS scale.

Exclusion criteria

* Multilevel surgery with osteotomy within the last 12 months. * Microtenotomies or percutaneous needle lengthening (APAI) within the last 9months. * Botulinum toxin injections within the last 3 months. * Participation in specific strength training protocols. * Lack of cognitive ability to perform the intervention protocol activities.

Design outcomes

Primary

MeasureTime frameDescription
Functional Percentile Based on Gross Motor Function Classification System (GMFCS)Baseline (pre-intervention) and immediately post-intervention (at 18 weeks).This variable represents the functional percentile calculated using the Gross Motor Function Classification System (GMFCS) and related measures. It incorporates: 1)GMFCS: A five-level system classifying gross motor movement capacity; 2) GrossMotor Function Measure (GMFM-66 and GMFM-88): Tools for evaluating grossmotor function across multiple dimensions; and 3) GMAE-2 Software: Generatesfunctional percentiles based on GMFM data. Values range from 0 to 100, where 0 represents the lowest functional percentile and 100 the highest.

Secondary

MeasureTime frameDescription
Quality of Life Assessed with CP-QOL QuestionnaireBaseline (pre-intervention) and immediately post-intervention (at 18 weeks).This variable evaluates the quality of life of caregivers and adolescents using theCerebral Palsy Quality of Life Questionnaire (CP-QOL). The questionnaireassesses multiple domains of well-being and quality of life related to cerebral palsy.Values depend on the raw or normalized scores, which may vary depending on thescoring method. If normalized, scores range from 0 (lowest quality of life) to 100(highest quality of life).
Participation in Daily Environments Assessed with PEM-CYBaseline(pre-intervention) and immediately post-intervention (at 18 weeks).This variable measures the participation of children and adolescents aged 5-18years in daily environments using the Participation and Environment Measure forChildren and Youth (PEM-CY). The PEM-CY evaluates both the frequency ofparticipation in various activities and the impact of environmental factors. Valuesare reported on scales specific to PEM-CY domains, where higher scores indicategreater participation and/or better environmental support.
Baseline Heart RateBaseline (pre-intervention) and immediately post-intervention (at 18 weeks).This variable represents the baseline heart rate, measured in beats per minute(bpm). It is recorded under resting conditions prior to any intervention or physicalactivity. Values range from 40 to 120 bpm, where lower values are associated withgreater tolerance to exercise.

Countries

Spain

Contacts

Primary ContactM.Luz Sánchez-Sánchez, PhD
m.luz.sanchez@uv.es963983853

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026